Document is current

Any future updates will be listed below

Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

Crossref DOI link: https://doi.org/10.1007/s00259-015-3025-6

Published Online: 2015-03-20

Published Print: 2015-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark